Biosimilars Business Trends & Latest Market Research

BiosimilarsSpecialty Physicians Discuss their Opinions of the United States Biosimilars MarketMulti-therapy Drugs: Opportunities for Generics & BiosimilarsBiosimilar Opportunities: Pipelines and CompaniesBiologics Price Competition and Innovation (BPCI) Act - Industry Trends Creating Demand for BiosimilarsBiosimilars: Japan UpdateHot Topics in Multiple Sclerosis: US Prescriber Perception of Biosimilars - Brands to lose over a fifth of patients to copy-cat drugsSouth Korea: Generics and Biosimilars OverviewGlobal Biosimilars Market AnalysisHospital Injectable Drugs: Future Prospects for Generics & BiosimilarsStrategic Analysis of Indian Biosimilar MarketGeneric Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive RevenuesCancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of BiosimilarsBiosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory EnvironmentBiosimilars and Follow-On Biologics: World Market 2011-2021Pharmaceutical Key Trends 2011 - Biosimilar Market OverviewBiologics/Biosimilars in Oncology: Blockbusters, Biosimilars, and Targeted Small Molecules Compete to Meet Unmet NeedsBiologics/Biosimilars in Immune and Inflammatory Disease: Will Novel Biologics and Biosimilars Disrupt Competitive Markets?Global Biosimilars (Follow-on biologics) Market: An AnalysisCountering Generic and Biosimilar ThreatsBiosimilars and Follow-On Biologics: Global Market Outlook 2010-2025Biosimilars: A Growing MarketBiotech/Biopharma/Biosimilar Review and Outlook 2010The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory PathwaysBiosimilars: Beyond the First Product WaveBiosimilars (2009 - 2014)The World Market for Biosimilars and the Potential for US Follow-on BiologicsEuropean Biosimilars Market OutlookBiogenerics: The World Market for BiosimilarsThe Future Of Biosimilars: Key Opportunities & Emerging TherapiesPricing and Reimbursement Issues for Generics and BiosimilarsThe Market for Generic Biologics: Issues, Trends, and Market Potential, 2nd edition